References He L
If you have concerns about pain or side effects, our team is happy to discuss these with you before your treatment, ensuring you feel informed and comfortable every step of the way
These are legitimate clinical decisions, but they are provider policy rather than universal medical fact which is why one clinic may decline where another accepts, and why a decline is not necessarily a statement that you can never be treated
performed a cross-trial analysis using data from clinical trials of GLP-1RAs (ELIXA, LEADER, SUSTAIN-6, EXSCEL, HARMONY, REWIND, PIONEER-6 [59], and AMPLITUDE-O), SGLT2is (CANVAS and CREDENCE), and finerenone (FIDELIO-DKD and FIGARO-DKD) to estimate the effects of the triple combination therapy of GLP-1RA, SGLT2i, and finerenone using the actuarial method [60]